FRIDAY, NOVEMBER 24, 2017

Iowa seeing increase in influenza

The flu virus is progressing in Iowa. Read More »

Frost & Sullivan awards Protein Sciences for Flublok vaccine

Frost & Sullivan recognized the influenza vaccine developed by Protein Sciences Corporation, Flublock with the 2013 Global New Product Innovation Award, PR Newswire reported Monday. Read More »

Health care worker in Scotland confirmed to have Ebola

A case of Ebola has been reported in Scotland. Read More »

Study suggests genetic changes can help predict flu outbreaks

A study released Monday by St. Jude Children's Research Hospital suggests that monitoring changes in certain flu viruses could lead to early warning signs of possible global health emergencies. Read More »

Study suggests new malaria treatment for children

Scientists from the University of Western Australia recently used a combination of artemisinin-naphthoquine to create a new drug therapy for children diagnosed with uncomplicated malaria. Read More »

Study indicates new strategy to treat tuberculosis

Researchers at Johns Hopkins University School of Medicine recently created a new treatment strategy using lower doses of a toxic tuberculosis drug without losing its efficacy. Read More »

Mylan to supply ARV drugs to South Africa for three years

Mylan, Inc., said on Wednesday that its subsidiary in India, Mylan Laboratories, Ltd., has been chosen to be a top supplier of antiretroviral (ARV) medications to the South African National Department of Health. Read More »

Shingles vaccine shows promise in test subjects age 50 and up

GlaxoSmithKline (GSK) has created a new vaccine that in a recent Zoster Efficacy study demonstrated the ability to reduce shingles in people 50 and older, the Center for the Biology of Chronic Disease (CBCD) said Wednesday. Read More »